fMRI hints 'will' and 'grace' are not equally honest
Honest people tell the truth, even when given a chance to lie, as shown in an fMRI brain study of truth telling and prevarication from Harvard behavioral scientists.
Honest people tell the truth, even when given a chance to lie, as shown in an fMRI brain study of truth telling and prevarication from Harvard behavioral scientists.
The group, led by Joshua Greene, an assistant professor of psychology at Harvard, assessed 35 subjects who attempted to predict random coin flip outcomes while undergoing fMRI. Rewarded for accuracy and punished for inaccuracy, the study design also allowed them to cheat. Researchers found honest individuals displayed little to no additional neural activity in control-related brain regions when telling the truth, but liars did. Prevailing theories behind lie detection, “will” and “grace,” hypothesize that honesty results either from an active resistance to temptation or from a lack of response to it. Study findings lean toward the latter, according to researchers (Proc Natl Acad Sci USA 2009).
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
